Cure51 Company Profile: Funding, Investors & Partnerships

Cure51

Cure51's proprietary data collection system, based on long-term partnerships, enables the creation of a single multimodal and multi-omics database of Outliers. Using its proprietary discovery platform powered by computational modeling, Cure51 aims to understand the biological mechanisms responsible for this exceptional survival by identifying and validating targets that can act on these interactions, leading to first-order treatments. Cure51's proprietary data collection system, based on long-term partnerships, enables the creation o Show More

Alpha Score

58.2

Total Funding$ 16.37 M